NeisVac-C, Injektionssuspension

7680006560017 CH-656 Injektionssuspension
NeisVac-C, Injektionssuspension
NeisVac-C, Injektionssuspension
NeisVac-C, Injektionssuspension
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
20/09/2023
Summary of Product Characteristics
Français
20/09/2023
Summary of Product Characteristics
Italien
20/09/2023

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIIS
(N/A)
0.5 MG Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.6 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 45.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2003

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
656
Drug name
NeisVac-C, Injektionssuspension
Galenic form
INJFS
ATC Code
J07AH07
Authorization status
Z
Dispensing category
B
First authorization
04/06/2002
Authorization expiration date
31/12/9999
IT Number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Meningokokken der Serogruppe C, ab dem vollendeten 2. Lebensmonat

Package details

Description (FR)
NEISVAC-C susp inj ser pré 0.5 ml
Description (DE)
NEISVAC-C Inj Susp Fertspr 0.5 ml
Market launch
04/06/2002
Narcotic (BTM)
No

Application methods

IMU

Other package sizes (1)

NEISVAC-C susp inj 10 ser pré 0.5 ml
None None
GTIN: 7680006560024
Not in V1